Recent Updates
Recently added Catalysts
ACB Positive Sentiment Score: 70/100

Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call NASDAQ | TSX

Key Takeaway: Aurora Cannabis has announced that it will hold a conference call on November 6, 2024, to discuss its financial results for the second quarter of the fiscal year 2025. The call will be led by CEO Miguel Martin and CFO Simona King. Financial results will be released before the market opens that same day, providing an opportunity for investors to engage with company leaders. This announcement underscores Aurora's commitment to transparency and investor relations in the cannabis industry.

Market Sentiment Analysis

POSITIVE FACTORS

  • Aurora Cannabis is hosting a conference call to discuss positive financial results.
  • The event highlights Aurora's proactive communication with investors.
  • The company continues to establish itself as a leading player in the global cannabis market.

Full Press Release Details

Aurora Cannabis to Host Second Quarter 2025 Investor
EDMONTON, AB, Oct. 24, 2024 /CNW/ - Aurora Cannabis
Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company,
announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wednesday,
November 6, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter
2025 before the opening of markets that same day.
Conference Call Details
DATE: Wednesday, November 6, 2024
TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time
WEBCAST: Click Here
Miguel Martin, Chairman and Chief Executive Officer,
and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted
to the Company's "Investor Info" link at https://www.auroramj.com/investors/ under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both
the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alberta, Aurora is a pioneer
in global cannabis, dedicated to helping people improve their lives. The Company's adult- use brand portfolio includes Drift, San
Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical
Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo
Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on
high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational
Aurora's common shares trade on the NASDAQ and TSX
under the symbol "ACB".
For Media: For Investors:
Michelle Lefler ICR, Inc.
VP, Communications & PR Investor Relations
media@auroramj.com aurora@icrinc.com
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable securities law ("forward-looking statements").
Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project",
"intend", "believe", "anticipate", "estimate", "may", "will", "potential",
"proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.
Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release
of the Company's Fiscal 2025 Q2 financial statements and the conference call to discuss the results.
These forward-looking statements are only predictions.
Forward looking information or statements contained in this news release have been developed based on assumptions management considers
to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly
available information from governmental sources as well as from market research and industry analysis and on assumptions based on data
and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks,
uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events,
results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking
statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure
to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and
retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand
in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration
of acquired business and operations (with respect to the Transaction and more generally with respect to future acquisitions), management's
estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities,
the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand,
changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry,
epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors"
in the Company's annual information from dated June 20, 2024 (the "AIF") and filed with Canadian securities regulators available
on the Company's issuer profile on SEDAR+ at www.sedarplus.com and filed with and available on the SEC's website at www.sec.gov.
The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors
could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating
the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation,
and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information,
future events or otherwise, except as expressly required by applicable securities law.
SOURCE Aurora Cannabis Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2024/24/c7381.html
CO: Aurora Cannabis Inc.
CNW 17:45e 24-OCT-24

Frequently Asked Questions

When is Aurora Cannabis's Q2 2025 conference call?

The conference call is scheduled for November 6, 2024, at 8:00 a.m. ET.

Who will host the conference call?

Miguel Martin, CEO, and Simona King, CFO, will host the call.

Where can I access the conference call webcast?

The webcast link is available on Aurora's Investor Info page.

What will be discussed during the call?

The call will cover Aurora’s financial results for Q2 2025.

How does Aurora Cannabis serve its markets?

Aurora serves both medical and consumer markets across multiple regions.

Last updated: Oct 24, 2024